Shao M, Chen D, Wang Q, Guo F, et al. Canagliflozin regulates metabolic reprogramming in diabetic kidney disease by inducing fasting-like and aestivation-like metabolic patterns. Diabetologia 2024 Jan 18. doi: 10.1007/s00125-023-06078.
PMID: 38236410